» Articles » PMID: 28165909

Intentional Weight Loss and Endometrial Cancer Risk

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2017 Feb 7
PMID 28165909
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Although obesity is an established endometrial cancer risk factor, information about the influence of weight loss on endometrial cancer risk in postmenopausal women is limited. Therefore, we evaluated associations among weight change by intentionality with endometrial cancer in the Women's Health Initiative (WHI) observational study. Patients and Methods Postmenopausal women (N = 36,794) ages 50 to 79 years at WHI enrollment had their body weights measured and body mass indices calculated at baseline and at year 3. Weight change during that period was categorized as follows: stable (change within ± 5%), loss (change ≥ 5%), and gain (change ≥ 5%). Weight loss intentionality was assessed via self-report at year 3; change was characterized as intentional or unintentional. During the subsequent 11.4 years (mean) of follow-up, 566 incident endometrial cancer occurrences were confirmed by medical record review. Multivariable Cox proportional hazards regression models were used to evaluate relationships (hazard ratios [HRs] and 95% CIs) between weight change and endometrial cancer incidence. Results In multivariable analyses, compared with women who had stable weight (± 5%), women with weight loss had a significantly lower endometrial cancer risk (HR, 0.71; 95% CI, 0.54 to 0.95). The association was strongest among obese women with intentional weight loss (HR, 0.44; 95% CI, 0.25 to 0.78). Weight gain (≥ 10 pounds) was associated with a higher endometrial cancer risk than was stable weight, especially among women who had never used hormones. Conclusion Intentional weight loss in postmenopausal women is associated with a lower endometrial cancer risk, especially among women with obesity. These findings should motivate programs for weight loss in obese postmenopausal women.

Citing Articles

Risk Stratification for Endometrial Cancer Reveals Independent Contributions of Polygenic Risk and Body Mass Index.

Wang X, Dossus L, Gunter M, Crosbie E, Ong J, Glubb D medRxiv. 2025; .

PMID: 40034786 PMC: 11875273. DOI: 10.1101/2025.02.19.25322538.


Models for predicting risk of endometrial cancer: a systematic review.

Forder B, Ardasheva A, Atha K, Nentwich H, Abhari R, Kartsonaki C Diagn Progn Res. 2025; 9(1):3.

PMID: 39901248 PMC: 11792366. DOI: 10.1186/s41512-024-00178-0.


Effect of weight loss following Roux-en-Y gastric bypass on cancer risk: A Mendelian randomization study.

Xue J, Chen S, Wang Y, Jiao Y, Wang D, Zhao J Medicine (Baltimore). 2025; 104(5):e41351.

PMID: 39889174 PMC: 11789913. DOI: 10.1097/MD.0000000000041351.


Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer.

Zhu C, Lai Y, Liu C, Teng L, Zhu Y, Lin X Front Pharmacol. 2024; 15:1387243.

PMID: 39104385 PMC: 11298396. DOI: 10.3389/fphar.2024.1387243.


Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer.

Zhao Z, Wang J, Kong W, Fang Z, Coleman M, Milne G Gynecol Oncol. 2024; 186:126-136.

PMID: 38669767 PMC: 11216885. DOI: 10.1016/j.ygyno.2024.04.012.


References
1.
Friedenreich C, Cust A, Lahmann P, Steindorf K, Boutron-Ruault M, Clavel-Chapelon F . Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control. 2007; 18(4):399-413. DOI: 10.1007/s10552-006-0113-8. View

2.
Nagle C, Marquart L, Bain C, OBrien S, Lahmann P, Quinn M . Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer. Eur J Cancer. 2013; 49(12):2717-26. DOI: 10.1016/j.ejca.2013.03.015. View

3.
. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998; 19(1):61-109. DOI: 10.1016/s0197-2456(97)00078-0. View

4.
Stefanick M, Cochrane B, Hsia J, Barad D, Liu J, Johnson S . The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol. 2003; 13(9 Suppl):S78-86. DOI: 10.1016/s1047-2797(03)00045-0. View

5.
Trentham-Dietz A, Nichols H, Hampton J, Newcomb P . Weight change and risk of endometrial cancer. Int J Epidemiol. 2005; 35(1):151-8. DOI: 10.1093/ije/dyi226. View